In: News

Get free access to our latest paper: “Laser-induced transient skin disruption to enhance cutaneous drug delivery”
September 22, 2020

Free access until November 07 to this article published in European Journal of Pharmaceutics and Biopharmaceutics.

Read More
María José Alonso receives the prestigious ‘Medal of Merit in Research and Education’ granted by the Government of Spain
July 28, 2020

María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and Nanomedicine. Her research is focused on designing novel nanostructured materials intended to transport drugs and antigens across biological barriers and deliver them to the target tissue, with the final goal of producing innovative nanomedicines and vaccines

Read More
Our latest paper, published in Frontiers in Immunology: “Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors”
July 8, 2020

Publication: Dacoba TG, Anfray C, Mainini F, Allavena P, Alonso MJ, Torres Andón F and Crecente-Campo J (2020) Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors. Front. Immunol. 11:1412. doi: 10.3389/fimmu.2020.01412

Read More
María José Alonso receives the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ of Controlled Release Society (CRS)
June 29, 2020

These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows. Alonso also received the “CRS Founders Award” granted by this scientific organization in 2018

Read More
Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery
June 22, 2020

In this review, we present an update of the current approaches and strategies carried out in the design of nanosystems and penetration-enhancing oral delivery strategies based on polyaminoacids.

Read More
María José Alonso, elected Secretary of the Controlled Release Society
María José Alonso leads a USC project aimed at developing a new vaccine against COVID-19 based on mRNA
May 11, 2020

Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS – University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.

Read More
María José Alonso, on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals
April 23, 2020

Professor Alonso is the only Spanish scientist in this ranking published by the magazine ‘The Medicine Maker’. This ranking highlights the career of the 60 most outstanding researchers worldwide in the areas of Small Molecules, Biopharmaceuticals, and Advanced Medicine

Read More
Get free access to our paper: “mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering”
April 22, 2020

Publication: Adriana M. Ledo, Ana Senra, Héctor Rilo-Álvarez, Erea Borrajo, Anxo Vidal, María J. Alonso, Marcos García-Fuentes, RNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering, Biomaterials, Vol. 247, July 2020 https://doi.org/10.1016/j.biomaterials.2020.120016. Free Access until May 26

Read More
María José Alonso, elected Secretary of the Controlled Release Society
The Controlled Release Society doubly awarded the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ to María José Alonso
March 4, 2020

These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows.

Read More
Our latest paper, published in Drug Delivery and Translational Research: “Technological challenges in the preclinical development of an HIV nanovaccine candidate”
February 28, 2020

In the obstacle race to the market nanomedicines face multiple challenges. If you want to know how to address them, check our recent paper about “Technological challenges in the preclinical development of an HIV nanovaccine candidate”, which has been just published in the DDTR journal.

Read More